desvenlafaxine

Generic: desvenlafaxine

Labeler: bryant ranch prepack
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name desvenlafaxine
Generic Name desvenlafaxine
Labeler bryant ranch prepack
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

desvenlafaxine succinate 25 mg/1

Manufacturer
Bryant Ranch Prepack

Identifiers & Regulatory

Product NDC 71335-2490
Product ID 71335-2490_2fb43907-14f4-422a-a75f-15ed93ccb250
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204028
Listing Expiration 2026-12-31
Marketing Start 2022-01-31

Pharmacologic Class

Classes
cytochrome p450 2d6 inhibitors [moa] norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 713352490
Hyphenated Format 71335-2490

Supplemental Identifiers

RxCUI
1607617
UNII
ZB22ENF0XR

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name desvenlafaxine (source: ndc)
Generic Name desvenlafaxine (source: ndc)
Application Number ANDA204028 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2490-1)
  • 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2490-2)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2490-3)
  • 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2490-4)
source: ndc

Packages (4)

71335-2490-1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2490-1) 71335-2490-2 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2490-2) 71335-2490-3 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2490-3) 71335-2490-4 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2490-4)

Ingredients (1)

desvenlafaxine succinate (25 mg/1)

Linked Drug Pages (1)

DESVENLAFAXINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2fb43907-14f4-422a-a75f-15ed93ccb250", "openfda": {"unii": ["ZB22ENF0XR"], "rxcui": ["1607617"], "spl_set_id": ["65f4a870-aa91-4d05-a32d-a161295bcc17"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2490-1)", "package_ndc": "71335-2490-1", "marketing_start_date": "20240918"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2490-2)", "package_ndc": "71335-2490-2", "marketing_start_date": "20240918"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2490-3)", "package_ndc": "71335-2490-3", "marketing_start_date": "20240918"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2490-4)", "package_ndc": "71335-2490-4", "marketing_start_date": "20240918"}], "brand_name": "DESVENLAFAXINE", "product_id": "71335-2490_2fb43907-14f4-422a-a75f-15ed93ccb250", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "71335-2490", "generic_name": "DESVENLAFAXINE", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DESVENLAFAXINE", "active_ingredients": [{"name": "DESVENLAFAXINE SUCCINATE", "strength": "25 mg/1"}], "application_number": "ANDA204028", "marketing_category": "ANDA", "marketing_start_date": "20220131", "listing_expiration_date": "20261231"}